BBX Capital Corporation (NYSE:BBX)
BBX Capital Corporation (NYSE:BBX) represented a move of 0 percent or $0.45 per share and closed its previous day trading session at $6.29. 0 Shares were traded in the last trading session with an Average Volume of 275.99 Million Shares. The stock currently has a Market Capitalization of 710.83 Million.
BBX Capital Corporation is a holding company whose principal holding is Bluegreen Corporation. The Company is involved in the acquisition, ownership and management of joint ventures and investments in real estate and real estate development projects, as well as acquisitions, investments and management of middle market operating businesses. BBX Capital Corporation, formerly known as BFC Financial Corporation, is based in FL, United States.
The stock traded between $ 5.54 and $10.17 over 1-Year time period showing its price to sales ratio of 0.76. BBX Capital Corporation (NYSE:BBX) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-1.27 and 200-Day Simple Moving Average of $-22.69. Its Price to Free Cash Flow is 0 and Price to Book of 1.06.
Analyst’s recommended the stock as 1.5 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, BBX Capital Corporation (NYSE:BBX) reported its Actual EPS of $0.06/share. The analysts offering Earnings Estimates for the company were believing that BBX Capital Corporation could bring EPS of $0.06/share. The difference between Actual EPS and Estimated EPS was 0 Percent. Thus showing an Earnings Surprise of 0 Percent.
Aptose Biosciences, Inc. (NASDAQ:APTO)
In the last trading session, Aptose Biosciences, Inc. (NASDAQ:APTO) added its value by 0% closing at the price of $2.18. The stock currently has market capitalization of 79.4 Million, with average volume of 213.42 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Aptose Biosciences, Inc. (NASDAQ:APTO) is showing beta of 1.87. This particular value of beta suggests that Aptose Biosciences, Inc. (NASDAQ:APTO) has historically moved 187% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Aptose Biosciences, Inc. (NASDAQ:APTO) is at $-0.81.
The stock currently has RSI of 47.23. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada.
Aptose Biosciences, Inc. (NASDAQ:APTO) topped its 52-week high price of $4.55 on 06/18/18 and 52-Week Low Price of $1.68 on 12/13/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 7.25% and monthly volatility of 9.12% respectively.